CompletedNot Applicable

Self- Administered Acupressure for Diarrhea Predominant Irritable Bowel Syndrome

Egypt70 participantsStarted 2023-02-05

Plain-language summary

This study aims to assess the effect of active self- administered acupressure compared to sham self- administered acupressure on the health outcome for patient with diarrhea predominant Irritable Bowel Syndrome

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with diarrhea irritable bowel syndrome symptoms following Rome IV diagnostic criteria * Agreed to be on a fixed dose of the pharmacological therapy throughout the study Exclusion Criteria: * Patients with severe lesions in major organs such as the heart, liver, and kidney, hematopoietic diseases, or tumors * Eating disorders * History of major abdominal surgery * History of neurological and mental illness * Usage of other treatment rather than the medical treatment regularly 2 weeks before randomization and throughout the study * Previous history of drug or alcohol abuse 6 months before randomization * Pregnant and lactating women. * Patient reporting of adequate relief of their irritable bowel syndrome symptoms the week preceding the randomization * Patient has too mild symptoms ( obtaining less than 75 on Irritable bowel syndrome symptoms severity scale at the baseline assessment) * Currently participating in other clinical trials

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Baseline mean of irritable Bowel Syndrome Symptom Severity Score

Timeframe: Immediately before assigning the participants to the study groups

Change from the baseline irritable Bowel Syndrome Symptom Severity Score at 2 weeks

Timeframe: after 2 weeks from the baseline

Change from the baseline irritable Bowel Syndrome Symptom Severity Score at 4 weeks

Timeframe: after 4 weeks from the baseline

Irritable Bowel Syndrome Adequate Relief question

Timeframe: At the baseline

Irritable Bowel Syndrome Adequate Relief question

Timeframe: After 2 weeks from the baseline

Irritable Bowel Syndrome Adequate Relief question

Timeframe: After 4 weeks from the baseline

Mean stool frequency after 2 weeks

Timeframe: After 2 weeks from the patient endorsement

Trial details

NCT IDNCT05702255

SponsorAlexandria University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-28

View on ClinicalTrials.gov More Irritable Bowel Syndrome With Diarrhea trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Baseline mean of irritable Bowel Syndrome Symptom Severity Score

Timeframe: Immediately before assigning the participants to the study groups

Change from the baseline irritable Bowel Syndrome Symptom Severity Score at 2 weeks

Timeframe: after 2 weeks from the baseline

Change from the baseline irritable Bowel Syndrome Symptom Severity Score at 4 weeks

Timeframe: after 4 weeks from the baseline

Irritable Bowel Syndrome Adequate Relief question

Timeframe: At the baseline

Irritable Bowel Syndrome Adequate Relief question

Timeframe: After 2 weeks from the baseline

Irritable Bowel Syndrome Adequate Relief question

Timeframe: After 4 weeks from the baseline

Mean stool frequency after 2 weeks

Timeframe: After 2 weeks from the patient endorsement